Research ExplorerPublicationsAnalyse der Erlössituation bei der ambulanten Behandlung nac...

Analyse der Erlössituation bei der ambulanten Behandlung nach 116 b SGB V am Beispiel des Marfan-Syndroms

Standard

Analyse der Erlössituation bei der ambulanten Behandlung nach 116 b SGB V am Beispiel des Marfan-Syndroms. / Manow, Marie-Luise; Paulsen, Nesrin; Rybczynski, Meike; Mir, Thomas; Bernhardt, Alexander M J; Treede, Hendrik; Ohm, Gunda; Fuisting, Bettina; Rehder, Uwe; Meier, Florian; Vogler, Marina; Meinertz, Thomas; Overlack, Karin; von Kodolitsch, Yskert.

In: MED KLIN-INTENSIVMED, Vol. 105, No. 8, 08.2010, p. 529-537.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Manow, M-L, Paulsen, N, Rybczynski, M, Mir, T, Bernhardt, AMJ, Treede, H, Ohm, G, Fuisting, B, Rehder, U, Meier, F, Vogler, M, Meinertz, T, Overlack, K & von Kodolitsch, Y 2010, 'Analyse der Erlössituation bei der ambulanten Behandlung nach 116 b SGB V am Beispiel des Marfan-Syndroms', MED KLIN-INTENSIVMED, vol. 105, no. 8, pp. 529-537. https://doi.org/10.1007/s00063-010-1090-y

APA

Manow, M-L., Paulsen, N., Rybczynski, M., Mir, T., Bernhardt, A. M. J., Treede, H., Ohm, G., Fuisting, B., Rehder, U., Meier, F., Vogler, M., Meinertz, T., Overlack, K., & von Kodolitsch, Y. (2010). Analyse der Erlössituation bei der ambulanten Behandlung nach 116 b SGB V am Beispiel des Marfan-Syndroms. MED KLIN-INTENSIVMED, 105(8), 529-537. https://doi.org/10.1007/s00063-010-1090-y

Vancouver

Manow M-L, Paulsen N, Rybczynski M, Mir T, Bernhardt AMJ, Treede H et al. Analyse der Erlössituation bei der ambulanten Behandlung nach 116 b SGB V am Beispiel des Marfan-Syndroms. MED KLIN-INTENSIVMED. 2010 Aug;105(8):529-537. https://doi.org/10.1007/s00063-010-1090-y

Bibtex

@article{5beb6c2b76b44bbc946b6953f1e7ba81,
title = "Analyse der Erl{\"o}ssituation bei der ambulanten Behandlung nach 116 b SGB V am Beispiel des Marfan-Syndroms",
abstract = "BACKGROUND: The Marfan syndrome is a typical rare disease with multiorgan involvement and the need for specialized interdisciplinary medical care. A novel German legal directive according to section sign 116 b of the Social Statutes Book V (116 b SGB V) improves options for reimbursement and thus encourages specialized hospitals to provide ambulatory care for rare diseases such as Marfan syndrome. The authors provide the first economic analysis of section sign 116 b in a German Marfan center.METHODS: The costs were assessed in 184 cases with Marfan syndrome receiving medical care in the Hamburg Marfan Clinic. The authors assessed the financial profit both according to payments received from invoices established according to the 116 b directive [reimbursement (116b)] and from calculations according to section sign 117 SGB V [reimbursement (117)].RESULTS: A total of 117 patients traveled to the Marfan clinic (64%) < 50 km, 27 patients (15%) between >or= 50 and 100 km. The total costs for ambulatory care were 71,606.28 Euro. The reimbursement (116b) was 55,549.87 Euro and the reimbursement (117) was 11,776.00 Euro.CONCLUSION: Many patients accept long distances of traveling to receive specialized ambulatory medical care. However, for optimal patient management specialized centers need to cooperate intensively with local health care providers. The novel legal directive according to section sign 116 b has significantly improved reimbursement for Marfan centers and allows for improving the quality of medical care.",
keywords = "Adolescent, Adult, Ambulatory Care/economics, Child, Child, Preschool, Cooperative Behavior, Costs and Cost Analysis, Female, Germany, Health Care Costs/legislation & jurisprudence, Health Expenditures/legislation & jurisprudence, Health Services Accessibility/economics, Hospitals, Special/economics, Humans, Infant, Interdisciplinary Communication, Male, Marfan Syndrome/economics, Middle Aged, National Health Programs/economics, Outpatient Clinics, Hospital/economics, Patient Care Team/economics, Rare Diseases, Referral and Consultation, Reimbursement Mechanisms/economics, Young Adult",
author = "Marie-Luise Manow and Nesrin Paulsen and Meike Rybczynski and Thomas Mir and Bernhardt, {Alexander M J} and Hendrik Treede and Gunda Ohm and Bettina Fuisting and Uwe Rehder and Florian Meier and Marina Vogler and Thomas Meinertz and Karin Overlack and {von Kodolitsch}, Yskert",
year = "2010",
month = aug,
doi = "10.1007/s00063-010-1090-y",
language = "Deutsch",
volume = "105",
pages = "529--537",
journal = "MED KLIN-INTENSIVMED",
issn = "2193-6218",
publisher = "Springer Medizin",
number = "8",

}

RIS

TY - JOUR

T1 - Analyse der Erlössituation bei der ambulanten Behandlung nach 116 b SGB V am Beispiel des Marfan-Syndroms

AU - Manow, Marie-Luise

AU - Paulsen, Nesrin

AU - Rybczynski, Meike

AU - Mir, Thomas

AU - Bernhardt, Alexander M J

AU - Treede, Hendrik

AU - Ohm, Gunda

AU - Fuisting, Bettina

AU - Rehder, Uwe

AU - Meier, Florian

AU - Vogler, Marina

AU - Meinertz, Thomas

AU - Overlack, Karin

AU - von Kodolitsch, Yskert

PY - 2010/8

Y1 - 2010/8

N2 - BACKGROUND: The Marfan syndrome is a typical rare disease with multiorgan involvement and the need for specialized interdisciplinary medical care. A novel German legal directive according to section sign 116 b of the Social Statutes Book V (116 b SGB V) improves options for reimbursement and thus encourages specialized hospitals to provide ambulatory care for rare diseases such as Marfan syndrome. The authors provide the first economic analysis of section sign 116 b in a German Marfan center.METHODS: The costs were assessed in 184 cases with Marfan syndrome receiving medical care in the Hamburg Marfan Clinic. The authors assessed the financial profit both according to payments received from invoices established according to the 116 b directive [reimbursement (116b)] and from calculations according to section sign 117 SGB V [reimbursement (117)].RESULTS: A total of 117 patients traveled to the Marfan clinic (64%) < 50 km, 27 patients (15%) between >or= 50 and 100 km. The total costs for ambulatory care were 71,606.28 Euro. The reimbursement (116b) was 55,549.87 Euro and the reimbursement (117) was 11,776.00 Euro.CONCLUSION: Many patients accept long distances of traveling to receive specialized ambulatory medical care. However, for optimal patient management specialized centers need to cooperate intensively with local health care providers. The novel legal directive according to section sign 116 b has significantly improved reimbursement for Marfan centers and allows for improving the quality of medical care.

AB - BACKGROUND: The Marfan syndrome is a typical rare disease with multiorgan involvement and the need for specialized interdisciplinary medical care. A novel German legal directive according to section sign 116 b of the Social Statutes Book V (116 b SGB V) improves options for reimbursement and thus encourages specialized hospitals to provide ambulatory care for rare diseases such as Marfan syndrome. The authors provide the first economic analysis of section sign 116 b in a German Marfan center.METHODS: The costs were assessed in 184 cases with Marfan syndrome receiving medical care in the Hamburg Marfan Clinic. The authors assessed the financial profit both according to payments received from invoices established according to the 116 b directive [reimbursement (116b)] and from calculations according to section sign 117 SGB V [reimbursement (117)].RESULTS: A total of 117 patients traveled to the Marfan clinic (64%) < 50 km, 27 patients (15%) between >or= 50 and 100 km. The total costs for ambulatory care were 71,606.28 Euro. The reimbursement (116b) was 55,549.87 Euro and the reimbursement (117) was 11,776.00 Euro.CONCLUSION: Many patients accept long distances of traveling to receive specialized ambulatory medical care. However, for optimal patient management specialized centers need to cooperate intensively with local health care providers. The novel legal directive according to section sign 116 b has significantly improved reimbursement for Marfan centers and allows for improving the quality of medical care.

KW - Adolescent

KW - Adult

KW - Ambulatory Care/economics

KW - Child

KW - Child, Preschool

KW - Cooperative Behavior

KW - Costs and Cost Analysis

KW - Female

KW - Germany

KW - Health Care Costs/legislation & jurisprudence

KW - Health Expenditures/legislation & jurisprudence

KW - Health Services Accessibility/economics

KW - Hospitals, Special/economics

KW - Humans

KW - Infant

KW - Interdisciplinary Communication

KW - Male

KW - Marfan Syndrome/economics

KW - Middle Aged

KW - National Health Programs/economics

KW - Outpatient Clinics, Hospital/economics

KW - Patient Care Team/economics

KW - Rare Diseases

KW - Referral and Consultation

KW - Reimbursement Mechanisms/economics

KW - Young Adult

U2 - 10.1007/s00063-010-1090-y

DO - 10.1007/s00063-010-1090-y

M3 - SCORING: Zeitschriftenaufsatz

C2 - 20824410

VL - 105

SP - 529

EP - 537

JO - MED KLIN-INTENSIVMED

JF - MED KLIN-INTENSIVMED

SN - 2193-6218

IS - 8

ER -